🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

Bayer AG (BAYNN)

BIVA
Currency in MXN
570.00
0.00(0.00%)
Closed
Trading near 52-week High
Fair Value
Day's Range
570.00570.00
52 wk Range
501.00570.00
Prev. Close
-
Open
570
Day's Range
570-570
52 wk Range
501-570
Volume
0
Average Volume (3m)
2
1-Year Change
-39.42%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
BAYNN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
34.75
Upside
+39.61%
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
Show more

Bayer AG NA Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Employees
96567
Market
Germany

Compare BAYNN to Peers and Sector

Metrics to compare
BAYNN
Peers
Sector
Relationship
P/E Ratio
0.0x19.4x−0.6x
PEG Ratio
0.000.050.00
Price/Book
0.0x2.3x2.6x
Price / LTM Sales
0.0x2.7x3.2x
Upside (Analyst Target)
0.0%63.4%47.5%
Fair Value Upside
Unlock12.0%6.7%Unlock

People Also Watch

72.935
BMWG
+0.32%
15.710
DBKGn
-0.36%
214.380
SAPG
+0.27%
616.30
ASML
-0.31%
55.920
MBGn
-0.46%

FAQ

What Is the Bayer (BAYNN) Stock Price Today?

The Bayer stock price today is 570.00

What Stock Exchange Does Bayer Trade On?

Bayer is listed and trades on the BIVA stock exchange.

What Is the Stock Symbol for Bayer?

The stock symbol for Bayer is "BAYNN."

What Is the Bayer Market Cap?

As of today, Bayer market cap is 536.82B.

From a Technical Analysis Perspective, Is BAYNN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.